Market News AIOpen the app

IceCure Medical has started treating its first patients in the ChoICE study approved by the FDA.

TrialRead the original at prnewswire.com
Good for ICCM

IceCure began enrolling patients in a study that could support wider use and payment coverage for ProSense. Only 2 of about 400 planned patients have enrolled, so that support is not yet proven.

ICCM · IceCure Medical Ltd.

AI read · Good for ICCM

The AI's read

This gives IceCure a way to gather evidence that could help more doctors use ProSense and secure payment coverage. The study also uses its sites as commercial centers. Enrollment has only just begun, so the study has not yet shown that wider use or coverage will follow.

Get alerts for ICCM

Follow IceCure Medical Ltd. (ICCM) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ICCM
Free on the App Store and Google Play, or on the web.